Colzyx AB (Colzyx) and the European Innovation Council Fund (EIC Fund) have signed the agreement for the first investment of EUR 1m in Colzyx by

Pre‐clinical work is concluded. The work confirms a superior in vivo effect of WOUNDCOM with respect to wound healing promotion, antibacterial effect and biocompatibility.

Collaboration Agreement is signed with global provider of peptide‐synthesis services

Ida Oja is recruited as Design and Development Manager of Colzyx.

Grant agreement is signed between Colzyx and the European Commission.